Quantcast
Channel: Medical Xpress news tagged with:neuroendocrine tumors
Viewing all articles
Browse latest Browse all 28

New drug shows improved progression-free survival for patients with advanced metastatic midgut neuroendocrine tumors

0
0
A new therapy in development for the treatment of midgut neuroendocrine tumors, a rare type of cancer that occurs in the small intestine and colon, shows improved progression-free survival and response rates for patients with advanced disease. Results of the international phase 3 clinical trial of lutetium-177 (177Lu)-Dotatate compared to high-dose octreotide LAR were published in the Jan. 12 issue of the New England Journal of Medicine.

Viewing all articles
Browse latest Browse all 28

Latest Images

Trending Articles





Latest Images